Clinical Trial Update: Pharmacokinetics of HLD200 in Children and Adolescents With ADHD [Phase 1, Phase 2]

View source ↗

Summary

A pharmacokinetics study of HLD200 in children and adolescents with ADHD, completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• HLD200

Snippet

Sponsor: Ironshore Pharmaceuticals and Development, Inc | Conditions: Attention-Deficit Hyperactivity Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-09-20